Insider · CIK 0001310204

Dickinson Andrew D

Reports to the SEC for 2 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001310204

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$145.29	−$436K	164,096
2026-09-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,797 sh	—	—	168,443
2026-09-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,797 sh	—	—	25,054
2026-09-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,347 sh	$144.81	−$195K	167,096
2026-08-17	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$138.36	−$415K	165,646
2026-07-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$129.93	−$390K	168,646
2026-06-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$125.40	−$376K	171,646
2026-06-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,796 sh	—	—	175,987
2026-06-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,341 sh	$121.48	−$163K	174,646
2026-06-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,796 sh	—	—	27,851
2026-05-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$132.27	−$397K	173,191
2026-04-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$140.96	−$423K	176,191
2026-03-16	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$144.23	−$433K	179,191
2026-03-10	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+35.9K sh	—	—	35,880
2026-03-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	Chief Financial Officer	AAward	+9,590 sh	—	—	30,647
2026-03-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,469 sh	—	—	185,338
2026-03-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−6,469 sh	—	—	21,057
2026-03-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,147 sh	$148.56	−$468K	182,191
2026-02-27	GILDGILEAD SCIENCES, INC.A Award	Chief Financial Officer	AAward	+11.1K sh	—	—	178,869
2026-02-17	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$154.43	−$463K	167,779
2026-02-03	GILDGILEAD SCIENCES, INC.A Award	Chief Financial Officer	AAward	+44.9K sh	—	—	195,370
2026-02-03	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−24.8K sh	$143.28	−$3.55M	170,568
2026-01-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$124.31	−$373K	150,503
2025-12-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$122.00	−$366K	153,503
2025-12-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,693 sh	—	—	158,248
2025-12-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,745 sh	$121.34	−$212K	156,503
2025-12-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,693 sh	—	—	27,526
2025-11-17	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−2,500 sh	$125.23	−$313K	154,555
2025-10-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−2,500 sh	$118.08	−$295K	157,055
2025-09-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−2,500 sh	$113.57	−$284K	159,555
2025-09-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,751 sh	$115.25	−$202K	162,055
2025-09-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,696 sh	—	—	31,219
2025-09-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,696 sh	—	—	163,806
2025-08-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−2,500 sh	$118.53	−$296K	160,110
2025-07-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−2,500 sh	$111.03	−$278K	162,610
2025-06-16	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−2,500 sh	$110.17	−$275K	165,110
2025-06-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,694 sh	—	—	169,368
2025-06-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,758 sh	$110.09	−$194K	167,610
2025-06-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,694 sh	—	—	34,915
2025-05-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−2,500 sh	$99.82	−$250K	165,674
2025-04-15	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−2,500 sh	$106.40	−$266K	168,174
2025-03-17	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−2,500 sh	$110.53	−$276K	170,674
2025-03-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,968 sh	—	—	177,029
2025-03-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,855 sh	$117.21	−$452K	173,174
2025-03-10	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+49K sh	—	—	49,020
2025-03-10	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,916 sh	—	—	13,013
2025-03-10	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−4,916 sh	$117.30	−$577K	182,074
2025-03-10	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−13K sh	—	—	0
2025-03-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	Chief Financial Officer	AAward	+11.1K sh	—	—	38,609
2025-03-10	GILDGILEAD SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−13K sh	$118.50	−$1.54M	169,061

Recent filings

Accepted (ET)
Sep 164
Dickinson Andrew D0001310204-26-000029
SEC(opens sec.gov)
Sep 114
Dickinson Andrew D0001310204-26-000027
SEC(opens sec.gov)
Aug 184
Dickinson Andrew D0001310204-26-000024
SEC(opens sec.gov)
Jul 164
Dickinson Andrew D0001310204-26-000022
SEC(opens sec.gov)
Jun 164
Dickinson Andrew D0001310204-26-000020
SEC(opens sec.gov)
Jun 114
Dickinson Andrew D0001310204-26-000018
SEC(opens sec.gov)
May 184
Dickinson Andrew D0001310204-26-000016
SEC(opens sec.gov)
Apr 164
Dickinson Andrew D0001310204-26-000014
SEC(opens sec.gov)
Mar 174
Dickinson Andrew D0001310204-26-000012
SEC(opens sec.gov)
Mar 124
Dickinson Andrew D0001310204-26-000010
SEC(opens sec.gov)
Mar 24
Dickinson Andrew D0001310204-26-000008
SEC(opens sec.gov)
Feb 184
Dickinson Andrew D0001310204-26-000006
SEC(opens sec.gov)

Companies

Address

GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE

FOSTER CITY, CA, 94404